PRAX logo

PRAX

Profile

Full Name

Praxis Precision Medicines, Inc.

Ticker Symbol

PRAX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 16, 2020

Indexes

Not included

Website

http://praxismedicines.com

Employees

116

Key Details

Price

$29.75(+0.03%)

Market cap

$599.86M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.55M(+249.53% YoY)

Annual EPS

-$10.21(+45.37% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$29.75
PRAX price is $29.75

30-Day Relative Volume

0.72
PRAX 30-day relative volume is 0.72

Price Performance

Price Most recent change

+0.03%
PRAX price was up +0.03% on Apr 14, 2025

Price YTD change

-61.34%
PRAX price is down -61.34% since January 1st

Price 1-year change

-44.28%
PRAX price is down -44.28% year-on-year

Price 3-year change

-77.04%
PRAX price is down -77.04% over the past 3 years

Price Range

Price All-time high

$914.26
PRAX price is currently -96.75% below its historical high of $914.26

Price 3-year low

$11.85
PRAX price is currently +151.05% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$599.86M
PRAX market capitalization is $599.86 million

Market cap 3-year change

+52.59%
PRAX market capitalization is up +52.59% over the past 3 years

Market cap All-time high

$2.30B
PRAX market capitalization is currently -73.96% below its historical high of $2.30 billion

Market cap sector rank

71.63%
PRAX market capitalization is higher than 71.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.86%
PRAX shares outstanding is up +17.86% year-on-year

Shares Outstanding 3-Year Change

+564.73%
PRAX shares outstanding is up +564.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
PRAX beta is 1.10

200-day SMA

$61.17
PRAX price is currently -51.37% below its 200-day simple moving average

50-day SMA

$51.67
PRAX price is currently -42.43% below its 50-day simple moving average

RSI

32.51
PRAX 14-day relative strength index is 32.51

Volume

0.72
PRAX 30-day relative volume is 0.72

ATR

$3.13
PRAX average true range is $3.13

10-day Historical Volatility

97.51%
PRAX 10-day historical volatility is 97.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$8.55M
PRAX annual revenue is $8.55 million

Revenue Analysts estimate

$1.33M
PRAX annual revenue is currently +542.07% higher than the consensus analysts' forecast

Revenue 1-year change

+249.53%
PRAX annual revenue is up +249.53% year-on-year

Revenue Sector rank

25.98%
PRAX annual revenue is higher than 25.98% of companies in Healthcare sector

EPS

EPS

-$10.21
PRAX annual earnings per share is -$10.21

EPS Analysts estimate

-$12.46
PRAX annual earnings per share is currently -18.03% lower than the consensus analysts' forecast

EPS 1-year change

+45.37%
PRAX annual earnings per share is up +45.37% year-on-year

EPS Sector rank

11.99%
PRAX annual earnings per share is higher than 11.99% of companies in Healthcare sector

Profit

Gross profit

-
PRAX annual gross profit value is unknown

Gross margin

-
PRAX annual gross profit margin value is unknown

Operating profit

-$200.16M
PRAX annual operating income is -$200.16 million

Operating margin

-2340.29%
PRAX annual operating profit margin is -2340.29%

Net income

-$182.82M
PRAX annual net profit is -$182.82 million

Net margin

-2137.48%
PRAX annual net profit margin is -2137.48%

Expenses

Total expenses

$208.72M
PRAX annual total expenses is $208.72 million

Operating expenses

$208.72M
PRAX annual total operating expenses is $208.72 million

Cost of goods sold

-
PRAX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$56.30M
PRAX annual SGA is $56.30 million

Depreciation and amortization

$358.00K
PRAX annual depreciation & amortization is $358.00 thousand

Interest expense

-
PRAX annual interest expense value is unknown

Income tax

-
PRAX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$200.16M
PRAX annual earnings before interest & taxes is -$200.16 million

EBITDA

-$199.81M
PRAX annual EBITDA is -$199.81 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$483.11M
PRAX annual total assets is $483.11 million

Non current assets

$78.74M
PRAX annual long term assets is $78.74 million

Current assets

$404.37M
PRAX annual total current assets is $404.37 million

Cash and cash equivalents

$215.37M
PRAX annual cash & cash equivalents is $215.37 million

Accounts receivable

-
PRAX annual accounts receivable value is unknown

Inventory

-
PRAX annual inventory value is unknown

Liabilities

Total liabilities

$37.66M
PRAX annual total liabilities is $37.66 million

Long term liabilities

$110.00K
PRAX annual total long term liabilities is $110.00 thousand

Current liabilities

$37.55M
PRAX annual total current liabilities is $37.55 million

Accounts payable

$12.53M
PRAX annual accounts payable is $12.53 million

Debt

Total debt

$1.37M
PRAX annual total debt is $1.37 million

Total debt 1-year change

-45.13%
PRAX annual total debt is down -45.13% year-on-year

Long term debt

$110.00K
PRAX annual long term debt is $110.00 thousand

Short term debt

$1.26M
PRAX annual short term debt is $1.26 million

Equity & Capital

Shareholders equity

$445.45M
PRAX annual stockholders equity is $445.45 million

Book value

$445.45M
PRAX annual book value is $445.45 million

Retained earnings

-$836.74M
PRAX annual retained earnings is -$836.74 million

Working capital

$366.82M
PRAX annual working capital is $366.82 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$131.76M
PRAX annual cash flow from operations is -$131.76 million

Cash from operations 1-year change

-18.55%
PRAX annual cash flow from operations is down -18.55% year-on-year

Cash from investing

-$248.49M
PRAX annual cash flow from investing activities is -$248.49 million

Cash from investing 1-year change

-737.98%
PRAX annual cash flow from investing activities is down -737.98% year-on-year

Cash from financing

$514.32M
PRAX annual cash flow from financing activities is $514.32 million

Cash from financing 1-year change

+459.83%
PRAX annual cash flow from financing activities is up +459.83% year-on-year

CAPEX

CAPEX

-
PRAX annual capital expenditures value is unknown

CAPEX 1-year change

-
PRAX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$131.76M
PRAX annual free cash flow is -$131.76 million

Free cash flow 1-year change

-18.5%
PRAX annual free cash flow is down -18.5% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PRAX annual gross profit margin value is unknown

Operating margin

-2340.29%
PRAX annual operating profit margin is -2340.29%

Net margin

-2137.48%
PRAX annual net profit margin is -2137.48%

ROA & ROE

ROA

-64.03%
PRAX annual return on assets is -64.03%

ROE

-70.98%
PRAX annual return on equity is -70.98%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PRAX price to earnings ratio value is unknown

PE ratio Sector rank

-
PRAX price to earnings ratio is unknown

PB Ratio

PB ratio

1.35
PRAX price to book ratio is 1.35

PB ratio Sector rank

51.93%
PRAX price to book ratio is higher than 51.93% of companies in Healthcare sector

PS Ratio

PS ratio

70.13
PRAX price to sales ratio is 70.13

PS ratio Sector rank

93.59%
PRAX price to sales ratio is higher than 93.59% of companies in Healthcare sector

Enterprise value

Enterprise value

$385.86M
PRAX enterprise value is $385.86 million

Enterprise value Sector rank

66.2%
PRAX enterprise value is higher than 66.2% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.93
PRAX EV/EBITDA is -1.93

EV/EBITDA Sector rank

32.61%
PRAX EV/EBITDA is higher than 32.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.77
PRAX annual current ratio is 10.77

Quick ratio

-
PRAX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
PRAX annual debt to equity ratio is 0.00

Interest coverage ratio

-
PRAX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PRAX piotroski f-score value is unknown

Altman Z-Score

6.69
PRAX altman z-score is 6.69

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Mar 3, 25 Truist Securities
Buy
Mar 3, 25 Needham
Buy
Mar 3, 25 HC Wainwright & Co.
Buy
Mar 3, 25 Baird
Outperform
Feb 11, 25 Deutsche Bank
Buy
Feb 10, 25 Needham
Buy
Jan 21, 25 Truist Securities
Buy
Dec 12, 24 HC Wainwright & Co.
Buy
Nov 7, 24 Needham
Buy

Institutional Ownership

Similar stocks

DNTH logo
Dianthus Therapeutics (DNTH)
KALV logo
KalVista Pharmaceuticals (KALV)
BFLY logo
Butterfly Network (BFLY)
FLGT logo
Fulgent Genetics (FLGT)
RXST logo
RxSight (RXST)
Bicara Therapeutics (BCAX)
REPL logo
Replimune (REPL)
TRVI logo
Trevi Therapeutics (TRVI)
AVBP logo
ArriVent BioPharma (AVBP)
  • What is the ticker symbol for Praxis Precision Medicines?
  • Does Praxis Precision Medicines pay dividends?
  • What sector is Praxis Precision Medicines in?
  • What industry is Praxis Precision Medicines in?
  • What country is Praxis Precision Medicines based in?
  • When did Praxis Precision Medicines go public?
  • Is Praxis Precision Medicines in the S&P 500?
  • Is Praxis Precision Medicines in the NASDAQ 100?
  • Is Praxis Precision Medicines in the Dow Jones?
  • When was Praxis Precision Medicines's last earnings report?
  • When does Praxis Precision Medicines report earnings?
  • Should I buy Praxis Precision Medicines stock now?

What is the ticker symbol for Praxis Precision Medicines?

The ticker symbol for Praxis Precision Medicines is NASDAQ:PRAX

Does Praxis Precision Medicines pay dividends?

No, Praxis Precision Medicines does not pay dividends

What sector is Praxis Precision Medicines in?

Praxis Precision Medicines is in the Healthcare sector

What industry is Praxis Precision Medicines in?

Praxis Precision Medicines is in the Biotechnology industry

What country is Praxis Precision Medicines based in?

Praxis Precision Medicines is headquartered in United States

When did Praxis Precision Medicines go public?

Praxis Precision Medicines's initial public offering (IPO) was on October 16, 2020

Is Praxis Precision Medicines in the S&P 500?

No, Praxis Precision Medicines is not included in the S&P 500 index

Is Praxis Precision Medicines in the NASDAQ 100?

No, Praxis Precision Medicines is not included in the NASDAQ 100 index

Is Praxis Precision Medicines in the Dow Jones?

No, Praxis Precision Medicines is not included in the Dow Jones index

When was Praxis Precision Medicines's last earnings report?

Praxis Precision Medicines's most recent earnings report was on Nov 6, 2024

When does Praxis Precision Medicines report earnings?

The next expected earnings date for Praxis Precision Medicines is May 9, 2025

Should I buy Praxis Precision Medicines stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page